TreeFrog Therapeutics

Kevin Alessandri, Ph.D., CEO and Chief Technology Officer
Bordeaux, France
(Private)
TreeFrog Therapeutics is a start-up company aiming at providing access to cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem, a high-throughput cell encapsulation technology allowing the mass-production and differentiation of stem cells in industrial bioreactors. This proprietary technology platform provides an end-to-end and scalable solution that will dramatically improve the quality of therapeutic cells and reduce treatment costs. Since its incorporation in November 2018, TreeFrog Therapeutics has experienced strong acceleration, securing over €13M in 2019. In January 2020, TreeFrog Therapeutics joined the FrenchTech120, an elite program for the fastest growing technology companies in France. The team – currently 26 staff – moved into a brand new production facility of 13,000 sq. ft. in June 2020.
www.treefrog.fr



By using this website you agree to accept our Privacy Policy and Terms & Conditions